News

Ormat Technologies Plans Exciting Financial Results Call Soon

Ormat Technologies Plans Exciting Financial Results Call Soon

Ormat Technologies Announces Upcoming Conference Call

Ormat Technologies, Inc. (NYSE: ORA), a pioneer in geothermal and renewable energy, is setting the stage for an important financial milestone. The company is gearing up to share its third quarter financial results, expected to be released after the market closes on a Monday in early November. Following this announcement, Ormat will host a conference call to delve into these results, inviting stakeholders to join in the discussion.

Details on the Conference Call

Scheduled for the following day at 9:00 a.m. ET, the conference call will be an excellent opportunity for investors and interested parties to gain insights into Ormat's financial performance. To ensure smooth participation, those in the United States and Canada can join by calling a dedicated number about 15 minutes before the call starts. International participants are also welcomed, with a separate number designated for their access. The call's access code will facilitate entry, and attendees are encouraged to mention the "Ormat Technologies, Inc. call" to the operator.

Accessing the Live Webcast

Alongside the audio conference, a live webcast will provide another medium for stakeholders to engage with the company's results. This webcast promises to enhance the accessibility of information, allowing investors to follow along with the discussions as they unfold.

What to Expect in the Financial Results

Investors are particularly keen on understanding how Ormat Technologies has performed in the third quarter. As one of the foremost companies in the renewable energy sector, their financial metrics are closely watched. Analysts are expected to scrutinize the company's revenue growth, operational efficiency, and advancements in technology. Additionally, any developments in energy storage initiatives or expansions into emerging markets are likely to be key talking points during the call.

Ormat's Vision for Growth

With over sixty years of experience, Ormat is not just resting on its past achievements. The company is focused on becoming a leader in various sectors within renewable energy, notably energy storage. Their innovative approach to geothermal and recovered energy generation is expected to play a significant role in their long-term strategy.

Company Overview and Market Positioning

Ormat Technologies has established a strong footprint in the geothermal energy landscape. As the only fully integrated company in this field, Ormat’s operations span from design and manufacturing to ownership of power plants. Currently, their global power generation capacity stands at approximately 3,400 MW. This includes a significant geothermal and solar generation portfolio across several countries including the U.S., Kenya, and Guatemala. This extensive experience equips Ormat to handle the complexities of renewable energy deployment effectively.

Focus on Energy Storage and Innovation

In addition to its geothermal capabilities, Ormat is making strides in energy storage services. Their commitment is reflected in the recently developed 350 MW energy storage portfolio located in the U.S. This initiative underscores Ormat’s intent to integrate renewable technologies with storage solutions, enhancing energy reliability and accessibility for consumers.

Contact Information for Investors

Those who wish to learn more about the conference call or Ormat's strategies can reach out for additional information. The company has established a clear channel of communication with its investors, ensuring that questions and inquiries are handled promptly.

Investor Relations Contact

For inquiries related to investor relations, Smadar Lavi serves as the VP and Head of IR and ESG Planning & Reporting, available at 775-356-9029. In addition, for those interested in engaging with the investor relations agency, reach out to Joseph Caminiti or Josh Carroll at Alpha IR Group, who can be contacted at 312-445-2870.

Frequently Asked Questions

What date is the financial results conference call scheduled for?

The conference call is set for 9:00 a.m. ET on a Tuesday in November.

How can I participate in the conference call?

You can join the call by dialing in approximately 15 minutes before it starts.

Where can I access the live webcast of the call?

The live webcast can be accessed through the Investor Relations section of Ormat's website.

What is the focus of Ormat Technologies' upcoming financial results?

The focus will be on Ormat's revenue growth, operational efficiency, and innovation in energy storage and geothermal technologies.

Who can I contact for more information about the company?

You can contact Smadar Lavi, VP, Head of IR, or connect with the Alpha IR Group for investor-related questions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

SKK Holdings Limited Announces Pricing for Share IPO Offering

Updated Category News Views 65

SKK Holdings Limited Announces Share Pricing for IPO SKK Holdings Limited (“SKK” or the “Company”) (Nasdaq: SKK), a specialized civil engineering service provider in subsurface utility works, has proudly announced the pricing of its initial public offering. The Company will offer 2,500,000 ordinary shares at a public offering price of $4.00 per share, yielding...

Continue Reading
Antelope Enterprise: Financial Performance Insights for 2024

Updated Category News Views 149

Antelope Enterprise Holdings Limited (NASDAQ: AEHL) hit the financial report stage hard back in mid-2024, flaunting numbers that tell quite the tale of both triumphs and tribulations. This company was hustling across two growing fronts: the fast-paced world of livestreaming ecommerce and the burgeoning energy sector down in Texas. Their half-year performance review...

Continue Reading
Olivier Falut Steps Into CFO Role at EUROAPI to Drive Growth

Updated Category News Views 344

Olivier Falut Joins EUROAPI as the New Chief Financial Officer EUROAPI is excited to announce the appointment of Olivier Falut as its new Chief Financial Officer, effective immediately. Olivier will be an integral member of the Executive Committee, succeeding Evelyne Nguyen. Evelyne will ensure continuity and a smooth transition within the company through her support...

Continue Reading
OPEXUS and Casepoint Join Forces for Growth and Innovation

Updated Category News Views 261

OPEXUS and Casepoint Unite for Strategic Growth In a significant development in the technology sector, OPEXUS, a frontrunner in government process management software, and Casepoint, an innovator in data discovery technology, have announced their merger. This significant move comes along with a majority investment from Thoma Bravo, a renowned software investment firm...

Continue Reading
MeiraGTx Holdings: An In-Depth Look at Future Potential

Updated Category News Views 69

MeiraGTx Holdings plc (NASDAQ:MGTX) was a clinical-stage gene therapy firm making waves back in 2024. The company announced a pivotal financial move, securing $50 million through equity financing at $4 per share, largely thanks to a $30 million investment from Sanofi (NYSE:SNY). While this funding boosted MGTX’s war chest, traders were already whispering about the heavy...

Continue Reading